Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 15, Issue 9
|
pp. 3480–3497
A novel signature based on cancer-associated fibroblast genes to predict prognosis, immune feature, and therapeutic response in breast cancer
Back to article
Figure 9
(9 of 11)
−
100%
+
Figure 9.
Prediction of immunotherapy response.
(
A
) The expression of immune checkpoints in low- and high-risk groups. (
B
) The relationship between risk score and the expression of some immune checkpoints.